Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

2016/04/04 by R. A. Devilee, Robin A C Devilee, Geert A. Simkens +11
Engineering · Medicine · #Intraperitoneal and Appendiceal Malignancies #Nanoplatforms for cancer theranostics #Occupational and environmental lung diseases

paper · doi:10.1245/s10434-016-5214-3

crossref issued 2016/04/04 · crossref published 2016/04/04 · crossref published-online 2016/04/04 · openalex publication_date 2016/04/04 · crossref created 2016/04/04 · crossref published-print 2016/09/01 · crossref deposited 2019/06/04 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/30

Citations

• Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis
• Bevacizumab Doubles the Early Postoperative Complication Rate after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal Origin
• Classification of Surgical Complications